Coronary Artery Bypass Graft Devices Market Size, Share, Growth, and Industry Analysis, By Type (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery and Quadruple CABG Surgery), By Application (Medical Application and Others), and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

CORONARY ARTERY BYPASS GRAFT DEVICES MARKET OVERVIEW

The global coronary artery bypass graft devices market size was USD 13.96 billion in 2025 and is projected to touch 14.88 billion by 2034, exhibiting a CAGR of 0.6% during the forecast period.

The world coronary artery bypass graft (CABG) devices market has been expanding steadily over the last ten years primarily because of the rising prevalence of various cardiovascular disorders across the globe and growing population of the elderly prone to heart diseases. The CABG on blood flow reversal is the most effective way, and CABG is still the best way to reverse the flow for patients with the artery being blocked, or stuck, so the market in grafts, catheters and anastomosis assist devices is huge demand. Increasing preference for minimally invasive and robotic-assisted surgeries that ensures recovery in short span of time and also supports precision in surgeries is expected to contribute to the growth of the market. Such drives are the prime market drivers for increasing the patient safety and efficiency of spinal surgeries and the invention of bioresorbable graft, more compatible connecters and smart surgical instruments are technologically driving the market. Furthermore, rising healthcare spending and government programs for prevention of cardiovascular diseases are encouraging hospitals and clinics to buy high-end CABG devices.

Rising consciousness among patients and expansion of healthcare infrastructure in emerging economies are also boosting the growth of the market. Increasing availability of cardiac treatment facilities and increasing medical tourism is driving demand for CABG surgeries in the Asian-Pacific and Latin American countries. But expensive nature of the procedure, stringent regulatory approvals and the factor that there are very skilled cardiac surgeons in huge quantity can restraint the market growth. Furthermore, continued clinical trials and studies on tissue-engineered grafts and novel surgical techniques offer new insights. Rising focus on R&D, along with collaborations with hospitals and research institutes, are anticipated to propel the global market growth in the long run.

COVID-19 IMPACT

Coronary Artery Bypass Graft Devices Industry Had a Negative Effect Due to supply chain disruption during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The immediate market impact of the COVID-19 epidemic was also noticeable on the CABG devices market due to postponement of elective and non-urgent heart surgeries. At the peak of the pandemic, hospitals across many regions had reallocated resources to care for patients with COVID-19, which meant fewer available operating rooms and staff for cardiac procedures. This has led to a decline in the short-term demand for CABG products, particularly in 2020 and early 2021. In addition, interruptions to supply chains made the timely acquisition of the necessary surgical tools and grafts difficult, delaying the numbers. But the market recovery began: healthcare systems pivoted, electives began resuming and vaccination efforts lightened the load of COVID-19 hospitalizations. This aspect has also led to the realization of the necessity to strengthen the medical infrastructure, bolstering investments in advanced surgical devices. This phase of recovery is driving new demand for CABG devices as hospitals move away from invasive and robotic assisted techniques that reduce hospital stays and risk of infection.

LATEST TRENDS

Advancements in Minimally Invasive Procedures and Bioengineered Grafts to Drive Market Growth

Growing adoption of minimally invasive and robotic assisted surgeries is one of the key trends contributing to the coronary artery bypass graft (CABG) devices market growth. These techniques are minimally invasive, lack trauma and quick recovery time, and have improved accuracy, which has been most welcomed by patients, as well as surgeons. Beyond this, the increased utilization of innovative imaging tools and intraoperative assessment systems in CABG surgery is enhancing its success through improved surgical precision and less complications. Another interesting development is the evolution in the materials and the devices for grafting such as bioresorbable grafts, tissue-engineered vascular grafts, and improved anastomosis assist devices that reduce the risk of infections and graft failure. The market also observes a rise in partnership between medical device manufacturers, research organizations, and healthcare service providers for the development of the next generation CABG products. And, greater emphasis on value-based healthcare is driving the adoption of devices that can improve clinical results while reducing the overall cost of treatment via efficiency improvements and longer-term durability.

•   
•   
  

  Request a Free sample to learn more about this report

    

CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into single CABG surgery, double CABG surgery, triple CABG surgery and quadruple CABG surgery

• Single CABG Surgery: It is performed when only one coronary artery is blocked and involves less complexity in compared to multiple bypass surgeries. It uses less number of grafts making the surgery shorter and the recovery is faster. Single CABG, a relatively good option, is recommended for localized coronary artery disease patients.

• Double CABG Surgery: During a double CABG procedure two of the coronary arteries are blocked, and the operation is slightly more complicated than a single bypass. It restores normal blood circulation for multivessel disease in patients. Rise in the prevalence of the mild coronary artery blockages will propel the demand for the procedure.

• Triple CABG Surgery: Triple bypass surgery is done when three arteries are occluded and is a highly complex surgical procedure. It’s riskier but the long-term health benefits are so great. It is commonly used in patients with significant coronary artery disease.

• Quadruple CABG Surgery: The Quadruple bypass or 4x bypass surgery deals with four blocked arteries, thus it is called quadruple bypass surgery one of the most complicated heart operations. It is often prescribed when patients have serious coronary artery blockages. Even though the recovery time is longer, it increases both the quality of life along with the overall recovery time.

By Application

Based on application, the global market can be categorized into medical application and others

• Medical Application: This division consists of hospitals, specialty clinics and cardiac centers where CABG is mostly conducted. Increase in prevalence of heart-related disease is augmenting the procedural volumes in these centers. Rising need for geriatrics care and use of highly sophisticated surgical equipment and devices are driving growth in this segment.

• Others: This group includes various research institutes, academic institutions, and training centers. CABG devices are used here for educational purposes, experimentation and developing new methods. It facilitates medical progress by sponsoring surgeon training and product testing.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising Prevalence of Cardiovascular Diseases to Boost the Market

Increasing burden of cardiovascular diseases is one of the key factors driving the coronary artery bypass graft devices market growth. Rising obesity, hypertension, and diabetes rates combined with poor diet, stress, and smoking have substantially increased the worldwide burden of coronary artery disease. As heart disease is still the number one cause of death in the world, the demand for successful surgical treatments is ever increasing. CABG procedures are widely viewed as the treatment of choice for patients with severe or multi-vessel blockages, which is contributing to increased need for grafts, connectors and anastomosis devices. Cardiovascular care is receiving more investment in terms of specialized centers and availability of advanced surgeries in developed as well as developing countries. The rising focus on health promotion, preventive health, and public awareness is also positively impacting early diagnosis and treatment, which in turn is augmented the demand for CABG devices. Consequently, the coronary artery bypass graft devices market is being driven by the pressing nature to counter the escalating cardiovascular disease population across the world.

Advancements in Surgical Technologies to Expand the Market

The market is being driven by progress in technology for coronary artery bypass graft devices. There is a growing problem of interest in minimally invasive and robotic-assisted procedures because these options lead to shorter hospitalization times, less surgical trauma and improved recovery in patients. These advances are especially advantageous for geriatric subjects with higher surgical risk. Innovations in graft materials, such as the ability to bio resorb and tissue-engineer grafts, are also contributing to long-term successes and safety. Furthermore, the advanced anastomosis device has better surgical accuracy and lower complications, and is helpful for the effectiveness and efficiency of CABG. These next-generation solutions are being increasingly implemented by hospitals and cardiac centers in order to improve treatment results and to address the increased need for value-based care. Ongoing R&D investment by medical device manufacturers will accelerate the market of coronary artery bypass graft devices market, marked by a robust footprint of advanced technology as a cornerstone to future growth.

Restraining Factor

High Cost of CABG Procedures and Devices to Potentially Impede Market Growth

High price of the coronary artery bypass graft (CABG) surgeries and devices is a key barrier for the growth of the coronary artery bypass graft devices market. It is considered not only one of the most costliest procedure after PTCA, with costly grafts, connectors and instruments, but even hospital charges, postoperative care and blood transfusion cost are high. In most areas, especially in low- and middle-income countries, patients encounter problems with affordability as health-insurance coverage can be limited and costs to the patient for care can be high. Even the developed countries could face as a major bottleneck the complexity of reimbursement which is also the main limiting factor to achieve wide spread applications. In addition, the price point for robotic-assisted and minimally invasive CABG is significantly greater than traditional therapies, which translates to reduced access for patients treated in resource-poor healthcare systems. Hospitals and clinics may also be reluctant to acquire expensive equipment when their budget might be tight and profits from use are far from guaranteed. This has retarded the pace of development of the coronary artery bypass graft devices market despite significant medical demand due to its higher costs.

Rising Demand in the Emerging Markets to Create Opportunity for the Product in the Market

Opportunity

Rising number of healthcare facilities and increase in adoption of advanced therapies in emerging economies is expected to offer lucrative opportunities for the coronary artery bypass graft devices industry. Asia-Pacific, Latin America and the Middle East nations experience increased investment along with cardiac care initiatives by the government and healthcare tourism. Growing disposable income and enhanced information on the cardiovascular health have caused a sharp rise in the number of patients willing to undergo advanced surgical treatments such as CABG surgeries in those countries. This changing trend has established huge opportunities for medical device makers to enter new market and reach to their new customers.

Furthermore, increasing collaboration of international medical device manufacturers with local healthcare service providers is making CABG appliances more affordable and accessible. Surgeons' training and new investments in modern hospitals are also driving the uptake of modern cardiac surgeries. Population thriving in these regions also contributes to the demand, thereby ensuring long term prospects. Combined, these factors provide a robust route for growth in the coronary artery bypass graft devices market by addressing underserved but burgeoning healthcare systems.

Increasing Adoption of Alternative Therapies Could Be a Potential Challenge for Consumers

Challenge

Increasing demand for treatments like angioplasty, stenting, and minimally invasive cardiac procedures, is a major factor for the growth of coronary artery bypass graft devices market. These procedures are much less-invasive, involve shorter hospital recoveries, and in many cases are a safer alternative to the traditional CABG surgery. The market for CABG devices is shrinking as improvements to interventional cardiology continue to show better outcomes and patients and doctors opt for less invasive alternatives.

Furthermore, stenting and percutaneous interventions are also economical and of easy access, particularly in cost-restricted areas. CABG is facing competition with the growing use of drug eluting stents and hybrid revascularization. By-passes are being ruled out because hospitals and healthcare networks desire faster recovery procedures that can facilitate a faster turnover rate for patients. Consequently, an increasing dependence on minimally invasive options is likely to temper the overall market expansion of the CABG devices market, and multiple companies are likely to innovate and differentiate as a result of this development.

•   
•   
  Request a Free sample to learn more about this report

    

CORONARY ARTERY BYPASS GRAFT DEVICES MARKET REGIONAL INSIGHTS

• North America

Rising prevalence of cardiovascular diseases and well-developed healthcare infrastructure is expected to boost the demand for the United States coronary artery bypass graft devices market. Obesity, sedentary lifestyle, the number of geriatric patients has contributed greatly to an increased requirement of coronary artery bypass operations. Furthermore, favorable reimbursement and greater availability of emerging surgical technology have helped accelerate the adoption of CABG devices in hospitals and specialty cardiac centers. Publisher's report confirms that leading medical device manufacturers have a significant presence in this market and also investments into research and development contribute to consolidate the market. Step-up in the trend towards minimally invasive CABG to improve. There also has been an increase in the patient preference towards minimally invasive CABG with the hospitals incorporating the robotics technology for the same. In combination, these elements contribute to North America’s over-developed status within the global coronary artery bypass graft devices market, cementing the region’s long-term growth prospects based on increased clinical requirements as well as ongoing industry support.

• Europe

The coronary artery bypass graft devices market share in Europe is expanding steadily due to the high incidence of cardiovascular disorders and the emphasis on advanced surgical solutions. Countries such as Germany, the United Kingdom, and France are leading contributors, supported by strong healthcare systems and significant government spending on cardiac care. Growing patient awareness about treatment options and increasing participation in cardiac screening programs have also contributed to higher procedure volumes. Technological advancements, including minimally invasive surgeries and improved grafting materials, are being rapidly adopted across European hospitals. Furthermore, collaborations between research institutions and device manufacturers are accelerating innovation in CABG technologies. With a strong base of skilled surgeons and favorable healthcare policies, Europe continues to strengthen its position in the global market. The rising burden of chronic illnesses and supportive government initiatives ensure that Europe remains an important region for sustained market growth.

• Asia

The coronary artery bypass graft devices market share in Asia is witnessing rapid expansion, fueled by the increasing prevalence of lifestyle-related diseases such as diabetes, hypertension, and obesity. Countries like China, India, and Japan are at the forefront, driven by large patient pools and rising cardiovascular disease burdens. Rapid urbanization, changing dietary patterns, and higher stress levels are contributing to escalating heart-related complications. Governments in the region are significantly investing in healthcare infrastructure, expanding access to cardiac care in both urban and semi-urban areas. The adoption of advanced CABG devices is also being supported by rising healthcare expenditure and the introduction of modern surgical facilities in leading hospitals. Additionally, growing awareness of preventive cardiac health and the availability of skilled medical professionals are driving the demand for CABG procedures. With continued economic development and expanding healthcare access, Asia represents one of the fastest-growing regions in the coronary artery bypass graft devices market.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key industry players in the coronary artery bypass graft devices market are focusing on strengthening their product portfolios and expanding global reach through research, innovation, and collaborations. Companies are investing in advanced graft materials, minimally invasive surgical solutions, and robotic-assisted technologies to enhance surgical outcomes and reduce patient recovery times. Strategic mergers, acquisitions, and partnerships are also being pursued to accelerate technological development and expand distribution networks. In addition, leading players are prioritizing regulatory approvals and clinical trials to ensure safety and efficacy, while also catering to the rising demand for customized surgical solutions. Efforts are equally directed toward expanding presence in emerging markets by addressing affordability and accessibility challenges, thereby tapping into the growing demand in developing economies. These collective initiatives are reinforcing competitiveness, improving patient care standards, and ensuring steady growth of the coronary artery bypass graft devices market on a global scale.

List Of Top Coronary Artery Bypass Graft Devices Companies

• Heratport (U.S.)
• Medtronic (U.S.)
• Guidant (U.S.)
• Terumo (Japan)
• Maquet (Germany)
• Sorin (Italy)
• Abbott (U.S.)
• Edward Life Sciences (U.S.)
• Boston Scientific (U.S.)
• Thoratec (U.S.)
• Articure (U.S.)
• Teleflex Medicals (U.S.)
• Biosense Webster (U.S.)

KEY INDUSTRY DEVELOPMENT

June 2023: Medtronic (United States) announced the launch of its advanced minimally invasive coronary artery bypass grafting device, designed to improve surgical precision and reduce recovery times. The innovation incorporates enhanced graft stabilization technology, which supports surgeons in performing complex multi-vessel bypass surgeries with greater accuracy. This development not only strengthens Medtronic’s portfolio in the coronary artery bypass graft devices market but also highlights its focus on driving patient-centric innovations that improve long-term clinical outcomes.

REPORT COVERAGE

The report on the coronary artery bypass graft devices market provides a comprehensive analysis of the industry, covering current trends, growth drivers, restraining factors, challenges, and emerging opportunities. It includes detailed segmentation by type, such as single, double, triple, and quadruple CABG surgeries, as well as by application, including medical and other uses. The study evaluates the impact of global events, including the COVID-19 pandemic, on market dynamics and surgical adoption rates.

Additionally, the report highlights key industry players, their strategic initiatives, research and development efforts, and regional presence. It provides in-depth regional insights, focusing on North America, Europe, and Asia, with emphasis on market growth and share in each region. Technological innovations, regulatory developments, and emerging trends are also covered to give stakeholders a forward-looking perspective. By examining industrial developments, partnerships, and product launches, the report serves as a valuable resource for investors, healthcare providers, and policymakers aiming to leverage growth opportunities in the coronary artery bypass graft devices market.